BNP Paribas is a global financial services company headquartered in Paris, France. Established in 1848, it operates through two primary divisions: Retail Banking and Services, and Corporate and Institutional Banking. The company offers a wide array of services, including long-term corporate financing, digital banking, wealth management, asset management, and investment services. It also provides global market services, security services, and corporate trade and treasury services to institutional and corporate clients. BNP Paribas Asset Management, a subsidiary, manages funds for individual and institutional investors, focusing on public equity and fixed income markets worldwide. Additionally, BNP Paribas Fortis, a Belgian subsidiary, offers corporate and investment banking, retail banking, and investment solutions. The company's extensive global network spans nearly 75 countries, serving a diverse range of clients from individuals to large corporations and public institutions.

The European Innovation Council (EIC), established in 2020 and headquartered in Brussels, Belgium, is dedicated to supporting high-potential innovators, entrepreneurs, small enterprises, and researchers. Its primary focus is on fostering early-stage startups that demonstrate significant environmental, social, and governance (ESG) impacts. The EIC collaborates with private investors to co-invest in ventures, particularly within the deep technology sector, aiming to drive innovation and sustainable development across Europe. By providing financial backing and resources, the EIC seeks to enhance the growth potential of promising startups and contribute to a more innovative and competitive European economy.

Innovation Industries, established in 2017, is a Dutch venture capital firm that invests in early-stage, high-tech, med-tech, and agri-foodtech companies. Based in Amsterdam, the firm manages multiple funds, including Innovation Industries Fund I, II, and III, with a focus on the Netherlands market. They provide capital up to EUR 25 million, typically taking minority stakes. Innovation Industries is known for its hands-on approach, actively supporting portfolio companies to strengthen their value proposition, accelerate time-to-market, and forge global strategic partnerships. The firm aims to be more than just a financial investor, acting as a partner to entrepreneurs and other stakeholders, helping to create and grow ventures.

Rockstart is an accelerator based in Amsterdam, Netherlands, founded in 2011. It specializes in early-stage investments in startups across various sectors, including energy, health, agrifood, and emerging technologies. With a strong focus on supporting purpose-driven founders, Rockstart not only provides capital but also offers coaching, mentorship, and access to markets, expertise, and a community of co-investors and partners. The company has invested in over 350 startups, achieving an alumni valuation exceeding $1.7 billion. Rockstart operates additional offices in Copenhagen, Denmark, and Bogotá, Colombia, and emphasizes impact-driven initiatives, including programs designed to assist entrepreneurs in Nepal. The firm's notable exits include companies like Wercker, Bouw7, and 3D Hubs, reflecting its commitment to fostering scalable innovations that drive positive change globally.

Parcom Capital, established in 1982, is a Dutch private equity firm with a pan-European focus. It invests in mid-sized companies, typically with enterprise values between €20 million and €200 million, revenues between €20 million and €500 million, and EBITDA between €5 million and €50 million. Parcom specializes in management buyouts, succession situations, and growth capital, often taking majority stakes and seeking board seats. It targets companies in the technology, trade and services, and production sectors, with a particular interest in those that incorporate sustainable operating practices. The firm has over €1.5 billion in capital and a longer-term investment horizon, aiming to support management teams in realizing their growth ambitions.

Invest-NL is an investment company focused on supporting innovative projects and sustainable initiatives in the Netherlands. It aims to stimulate economic growth by providing financing and expertise to businesses that contribute to the transition towards a more sustainable economy. Invest-NL plays a crucial role in identifying promising opportunities and facilitating investments that align with national priorities, particularly in areas such as renewable energy, technology, and infrastructure. By partnering with various stakeholders, including entrepreneurs and public entities, Invest-NL seeks to foster a vibrant ecosystem that encourages innovation and long-term value creation.

InnovationQuarter is the regional development agency for South Holland, established in 2013 and headquartered in The Hague. The agency focuses on funding innovative and rapidly growing companies while aiding foreign businesses in establishing operations within the region. It fosters collaboration among entrepreneurs, knowledge institutes, and government entities to drive innovation. Additionally, InnovationQuarter Capital offers diverse financing options, including equity investments and various types of loans, tailored for seed, early-stage, and growth companies. The agency targets investments across multiple sectors, including maritime, food, data science and artificial intelligence, biobased materials, horticulture, aerospace, life sciences, health, high-tech systems, energy, circular economy, information technology, and cybersecurity.

PMV Re Vinci nv, based in Brussels, Belgium, is primarily focused on real estate development. The company plays a significant role in fostering the Flemish economy by providing funding to promising businesses from their inception through various growth stages and into international operations. Collaborating with government entities and other partners, PMV implements projects that are vital for prosperity and well-being in Flanders. The organization is dedicated to supporting entrepreneurship as a key driver of economic development and believes that sustainable business ventures must ultimately achieve profitability. Through its investments, PMV aims to ensure that every supported project contributes positively to the economic landscape of Flanders.

Value Creation Capital B.V. is a private equity firm based in Bilthoven, Netherlands, founded in 2005. The firm specializes in investing in growth companies within the information technology sector, focusing on high-tech areas such as software as a service (SaaS), business software, cybersecurity, data analytics, and the Internet of Things. Value Creation Capital typically invests between $200,000 and $2 million and primarily targets the Benelux region. The firm aims to support its portfolio companies not only through financial investment but also by providing operational and strategic guidance in areas such as management and governance. With a proven track record of successful exits, Value Creation Capital is positioned to navigate and shape the rapidly evolving tech landscape while fostering innovation and development in its chosen sectors.

Volta Ventures, established in 2014, is a venture capital firm headquartered in Ghent, Belgium, with an additional office in Amsterdam. It specializes in providing seed and early-stage funding to internet and software companies based in the Benelux region. The firm's approach involves more than just capital; it actively supports founders and management teams by helping identify new markets and customers, aiding in senior talent recruitment, offering ongoing guidance, and facilitating further financing rounds. Volta Ventures works closely with a network of over 30 business angels to maximize its impact on investee companies.

Convent Capital is a private equity firm based in Amsterdam, Netherlands, established in 2011. The firm specializes in buy-outs, buy-ins, and growth capital investments in small and medium-sized enterprises, primarily focusing on companies headquartered in the Netherlands and those based in Belgium and Luxembourg. Convent Capital targets investments in businesses with an enterprise value ranging from €10 million to €50 million and an EBITDA between €2 million and €8 million. The firm emphasizes sustainability and seeks to create value through strategic and operational improvements. Convent Capital generally aims to acquire majority stakes in its portfolio companies, with a particular interest in the agriculture and food sectors.

The European Investment Bank (EIB), established in 1958, is a long-term lending institution owned by the EU Member States. Headquartered in Luxembourg, it offers a wide range of financing solutions, including project loans, loans to banks and intermediaries, venture capital funds, and equity investments. EIB also provides structured finance products, guarantees, and securitization instruments, along with advisory services for infrastructure projects, urban development, and small to medium-sized enterprises. Its portfolio is predominantly composed of loans (93.08%), with a small portion allocated to debt and fixed income, shares, and other assets. EIB's mission is to support European integration and social cohesion, primarily within the European Union and internationally.

FJ Labs, established in 2015 and headquartered in New York, is a stage-agnostic investment firm focusing on marketplaces and consumer-facing startups. It invests in seed and series A rounds, with a typical investment range of $50,000 to $5,000,000. The firm's portfolio includes notable companies such as Alibaba Group, Beepi, BrightRoll, Betterment, Adore Me, and Earnest, spanning sectors like e-commerce, fintech, and ad tech.

EASME is a European Union executive agency that supports small and medium-sized enterprises and promotes innovation in Europe. It manages projects in the areas of small and medium-sized enterprises, as well as the environment, energy, and maritime sectors, funded by COSME, LIFE, and EMFF. EASME organizes the European Sustainable Energy Week and serves industries such as environmental management, energy production, and maritime activities.

EQT is a global private equity and infrastructure firm founded in 1994, headquartered in Stockholm, Sweden. It specializes in buyouts, expansion capital, and infrastructure investments, focusing on mid-market companies with strong growth potential. EQT invests across various sectors, including healthcare, technology, services, industrials, and real estate, with a particular emphasis on Northern and Eastern Europe, Asia, and the US. The firm seeks to unlock growth potential in its portfolio companies, positioning them as sustainable market leaders, and typically holds investments for four to eight years. EQT also prioritizes ESG and impact investments in its infrastructure portfolio.

Capricorn Partners, established in 1993, is a Belgium-based asset management firm specializing in venture capital. It invests in innovative European companies that leverage technology for a competitive edge, focusing on sectors such as information technology, healthcare, and clean technology. The firm's investment team comprises experienced professionals with deep technology expertise and broad industrial experience.

BOM invests in innovative start-ups and growth companies. BOM objectives include improved economic growth, increased employment, and solutions to social problems. They offer expertise, resources, and connections through their network to create and finance renewable energy projects.

Insight Partners, established in 1995, is a global private equity and venture capital firm headquartered in New York City, with additional offices in London, Tel Aviv, and Palo Alto. The company specializes in investing in growth-stage technology and software companies, with a particular focus on sectors such as Fintech, Cybersecurity, AI/ML, DevOps, and Healthcare. As of December 31, 2022, Insight Partners has over $75 billion in regulatory assets under management. The firm has invested in more than 750 companies worldwide and has seen over 55 portfolio companies achieve an IPO. Insight Partners' mission is to partner with visionary executives, providing practical, hands-on software expertise along their growth journey, from initial investment to IPO.

BioGeneration Ventures, established in 2006, is a Dutch private equity firm specializing in early-stage investments in the life sciences sector, with a focus on the Benelux and Germany. The company invests in and supports start-up and early-stage life sciences companies, providing not just capital but also expertise and industry connections to accelerate their growth and optimize their commercial potential. Their portfolio spans therapeutics, medical devices, and diagnostics. Notable investors in their fund include Bristol-Myers Squibb, Johnson & Johnson, and Schroder Adveq.

ABN AMRO Bank N.V., established in 1720, is a prominent Dutch bank offering a comprehensive range of financial services to retail, private, and corporate clients both domestically and internationally. It operates through four primary segments: Retail Banking, Commercial Banking, Private Banking, and Corporate & Institutional Banking. The bank provides services such as savings accounts, credit cards, loans, mortgages, and wealth management, along with asset-based solutions, working capital solutions, and trade finance. ABN AMRO is committed to sustainability, with a dedicated fund investing in companies and projects contributing to the energy, circular, and social impact transitions. The bank is headquartered in Amsterdam, the Netherlands, and is one of the country's largest banks, serving clients through a network of branches, contact centers, and digital platforms.

Rivean Capital is a private equity firm established in 1982, headquartered in Utrecht, Netherlands. The firm focuses on investing in companies across various sectors, including transportation, chemicals, business services, food and beverage, information technology, consumer services, and industrial sectors. Rivean Capital primarily targets businesses located in the Benelux countries, the DACH region, and Italy, aiming to foster growth and development within these industries.

Forbion is a venture capital firm based in Naarden, Netherlands, established in 2006. It specializes in early-stage investments within the life sciences and MedTech sectors, focusing on companies involved in drug development and addressing critical medical needs. The firm has a team of nine investment professionals and has built a strong track record since the late 1990s, with successful investments in various notable companies. Forbion manages assets exceeding €400 million across three active funds and co-manages BioGeneration Ventures, which targets academic spin-outs and seed investments in the Netherlands. The firm continues to play a significant role in advancing innovative healthcare solutions through its strategic investments.

Gimv, established in 1980, is a Belgian-based investment company specializing in private equity and venture capital. With over 40 years of experience, Gimv manages a portfolio of 85 companies across Europe, generating a combined turnover of over EUR 6 billion and employing more than 28,000 professionals. The company focuses on business-to-business, financial services, healthcare, information technology, and other sectors, with a majority (75%) of its investments in private equity.

Rabobank Group, established in 1898 and headquartered in Utrecht, Netherlands, is a commercial bank that operates globally with a strong emphasis on the food, beverage, and agribusiness sectors. The bank provides a comprehensive range of services, including retail and wholesale banking, asset management, leasing, and real estate services. It specializes in farm financing, corporate banking, mergers and acquisitions, trade finance, and financial advisory services. With a focus on customer needs, Rabobank leverages its extensive network of industry specialists and researchers to deliver tailored solutions. The bank is recognized for its solid financial foundation, supported by a AAA credit rating, which allows it to offer various financing options, including long and short-term loans, overdrafts, and credit facilities. Operating in 46 countries, Rabobank is committed to fostering knowledge-driven relationships and providing innovative services to its clients in the agribusiness sector.

Newion Investments, established in 2000, is a Netherlands-based venture capital firm specializing in early-stage investments. It focuses on business-to-business (B2B) software companies, primarily in the Benelux region, with a secondary focus on the Nordics and Germany. The firm invests between €0.25 million and €2.5 million, seeking minority or majority stakes, and aims to exit within five to seven years. Newion provides portfolio companies with non-Executive Board Members and interim CFO services. It does not invest in retail, life sciences, real estate, or business-to-consumer focused companies, and avoids semiconductor, system integrator, and consulting propositions.

The Goldman Sachs Group, Inc., established in 1869, is a global leader in investment banking, securities, and investment management. It operates in four primary segments: Investment Banking, Institutional Client Services, Investing & Lending, and Investment Management. The company provides a wide range of services, including financial advisory services for mergers and acquisitions, underwriting services for various securities, client execution services for fixed income, currencies, commodities, and equities, securities services, and wealth advisory services. It serves a diverse client base comprising corporations, financial institutions, governments, and high-net-worth individuals. Additionally, Goldman Sachs invests in a broad array of asset classes, including debt securities, equity securities, real estate, and private equity, demonstrating its commitment to driving growth and innovation across industries.

Inkef, established in 2010, is a venture capital firm headquartered in Amsterdam, Netherlands. It specializes in early-stage investments, focusing on technology and healthcare sectors across Europe. Inkef is known for its patient, long-term approach, supporting entrepreneurs from the initial stages of their ventures and providing funding through multiple rounds to help build successful international businesses.

Waterland Private Equity Investments, established in 1999 and headquartered in Bussum, Netherlands, is a private equity firm that supports entrepreneurs and invests in medium-sized companies across Europe. The firm primarily focuses on buyout opportunities in sectors such as business products and services, information technology, consumer goods, and healthcare. Waterland's funds typically target investments ranging from EUR 5 million to EUR 150 million, aiming to support the growth ambitions of these companies.

PDENH is an investment management firm based in Amsterdam, Noord-Holland, that focuses on venture capital and private equity investments. Founded in 2014, the firm aims to identify and support innovative companies and projects, providing the necessary capital and expertise to foster growth and development in various sectors.

Thuja Capital, established in 2006, is a Netherlands-based investment firm specializing in early-stage healthcare and biotech companies. It focuses on medical product innovations for diagnosis, cure, care, or prevention, including medical devices, medtech, diagnostics, therapeutics, nutraceuticals, and digital health. Thuja Capital provides seed, start-up, and early-stage financing, typically investing between €0.25 million to €2.5 million in equity and €0.50 million to €1 million in debt. The firm, based in Utrecht, considers investments across the Benelux region and Western Europe, acting as both lead and co-investor, and often takes a seat on the supervisory board.

Fortino Capital I, established in 2016, is a Belgium-based venture capital fund managed by Fortino Capital Partners. The fund, founded in 2013, specializes in growth capital investments, focusing on early and mid-cycle business-to-business Software as a Service (SaaS) companies. Its primary investment sectors are software, communications, and networking, with a regional focus on Western Europe, particularly the Benelux countries. Fortino Capital I provides expansion capital and expertise to exceptional entrepreneurs, aiding in the development of growth-enabling SaaS platforms primarily designed for small and medium-sized enterprises (SMEs). Additionally, the fund supports companies aiming to reinvent their business models through best-in-class management practices and state-of-the-art technologies.

V-Bio Ventures is an independent venture capital firm based in Ghent, Belgium, founded in 2015. The firm specializes in building and financing innovative life science companies, focusing on start-up and early-stage ventures with significant growth potential. V-Bio Ventures primarily invests in the therapeutics, diagnostic therapies, and sustainable agriculture sectors across Europe. The firm is dedicated to supporting technologies that aim to deliver transformative improvements in the biotech, pharmaceutical, and agricultural industries.

VIB is a non-profit research institute established in 1966 and located in Zwijnaarde, Belgium. It specializes in life sciences research, focusing on applications in pharmaceuticals, agriculture, and industry. VIB collaborates closely with five prominent universities in Flanders—Ghent University, KU Leuven, University of Antwerp, Vrije Universiteit Brussel, and Hasselt University—to advance its research initiatives. The institute aims to contribute significantly to the life sciences sector by fostering innovation and development in various scientific fields.

Graduate Entrepreneur is a venture capital investment firm established in 2021 and headquartered in Rotterdam, Netherlands. The firm is dedicated to stimulating the start-up ecosystem in Delft and Rotterdam by investing in founders of innovative ventures at the pre-seed and seed stages. With a focus on supporting promising companies, Graduate Entrepreneur leverages an extensive network of successful entrepreneurs and a diverse array of supporters to assist entrepreneurs at various stages of their journey. Through this commitment, the firm aims to foster the growth and development of new businesses in the region.

Founded in 2011, Inventures Investment Partners is an impact investment firm based in Brussels, Belgium. The firm manages the impact venture capital funds, Inventures I, which focuses on societal goals including health, education, environment, economic growth, and social progress, and Inventures II, which invests early-stage capital in smart and innovative European SMEs answering at least one of the United Nations Sustainable Development Goals.

Accel, established in 1983, is a prominent venture capital firm headquartered in Palo Alto, California, with additional offices in San Francisco, London, and Bangalore. The firm specializes in investing in early and growth-stage technology startups, focusing on sectors such as software, cloud technologies, consumer services, enterprise, healthcare, fintech, and security. Accel's portfolio includes notable companies like Atlassian, Facebook, Slack, and Spotify, reflecting its ability to identify and support entrepreneurs building businesses that drive next-generation industries.

European Regional Development Fund encourages innovation, enhances regeneration, and provides support to businesses in the European Union.

Kurma Partners, established in 2009, is a Paris-based private equity and venture capital firm specializing in early-stage investments in healthcare and biotechnology sectors across Europe. The company focuses on financing innovation from pre-creation to development capital, supporting therapeutic and medical innovations, and collaborating with leading research institutes and hospitals. Kurma Partners manages several funds, including Kurma Biofund I, II, and Kurma Diagnostics, making it a significant player in European healthcare financing.

Main Capital V, established in 2017, is a buyout fund managed by Main Capital Partners, a Dutch private equity firm founded in 2003. The fund, based in The Hague, focuses on investing in software companies across Austria, Germany, and Switzerland. Its strategy is to form long-term, value-added partnerships with founders and management teams, aiming to create operational and strategic value and build large, healthy software groups driven by solid business fundamentals.

Allianz Global Investors, established in 1956, is a global investment management firm headquartered in Munich, Germany. With 23 offices across 18 countries, it offers a wide range of investment capabilities, including equity, fixed income, multi-asset, alternatives, and research. The firm serves both individual and institutional clients, managing over $436 billion in assets. Allianz Global Investors employs over 500 investment professionals, providing consultative local delivery with global investment and research capabilities. It is a subsidiary of Allianz SE, a strong parent company, and is known for its culture of risk management.

Asabys Partners is a Barcelona-based venture capital firm established in 2018 that focuses on investments in the life sciences and healthcare sectors. The firm targets innovative and transformative technologies within the health-tech and biopharma industries, both in Spain and internationally. Asabys Partners aims to advance the boundaries of science and medicine by financing disruptive technologies and collaborating with leading experts in the field.

NPM Capital N.V. is a private equity firm based in Amsterdam, Netherlands, founded in 1948. It specializes in providing buy-out, growth, and replacement capital primarily to family-owned businesses. The firm employs a buy-and-build strategy and engages in mid-market buy-outs, development capital, turnaround projects, and recapitalizations. NPM Capital typically invests in a variety of sectors, including food, healthcare, environment, medical services, manufacturing, internet technology, e-commerce, and energy, with a particular focus on medium and large companies within the Benelux region. The firm aims to support companies that are advancing digitalization, promoting healthy lifestyles, enhancing education, and contributing to sustainable futures. NPM Capital generally invests between €20 million and €200 million in its ventures.

UNIIQ is an investment fund based in The Hague, Netherlands, with a focus on the proof-of-concept phase. Established in 2016, it manages a fund of €22 million aimed at supporting entrepreneurs in South Holland in bringing their unique innovations to market. UNIIQ provides essential start-up capital to help bridge the most critical phase of transforming ideas into promising businesses. By collaborating closely with knowledge institutions and incubators, UNIIQ actively aids entrepreneurs in their strategic development. The investments made by UNIIQ are utilized for validating innovations and business concepts, with the ultimate goal of facilitating the transition to further financing. The fund emphasizes a straightforward process with favorable conditions for entrepreneurs, ensuring they can effectively move forward with their projects.

Participatiemaatschappij Vlaanderen, established in 1995 and based in Brussels, Belgium, is a government organization focused on investing in startup and growth-stage companies. The organization targets diverse sectors including media, software, retail, infrastructure, energy, and real estate. Its investment portfolio is structured with a significant allocation towards financial fixed assets and receivables, reflecting its commitment to supporting emerging businesses. Participatiemaatschappij Vlaanderen plays a crucial role in fostering innovation and entrepreneurship in Belgium by providing essential financial backing to projects at various stages of development.

Novo Holdings, established in 1999, is a Danish asset management firm based in Copenhagen. It serves as the investment arm of the Novo Nordisk Foundation, managing its assets and wealth. The company's primary focus is the life science sector, with a diversified portfolio comprising equities, bonds, real estate, infrastructure, and private investments. Novo Holdings maintains a significant influence on Novo Nordisk A/S and Novozymes A/S, ensuring these companies align with the Novo Group's visions and values. It also invests in early and growth-stage life science companies through its venture capital arm, Novo Ventures, which targets investments ranging from USD 5 million to USD 30 million.

Founded in 2016, Neope Capital Management is a private equity firm based in S-Hertogenbosch, Netherlands. The firm seeks to invest in companies that are active in the Netherlands, Germany, and the Flemish-speaking part of Belgium.

Belfius Bank is a banking institution based in Brussels, Belgium, established in 1996 to serve the financial needs of local authorities and the broader community. The bank focuses on collecting savings deposits and investments through its distribution networks across Belgium. It reinvests these funds into society by providing loans to individuals, self-employed individuals, small and medium-sized enterprises, as well as corporate, public, and social institutions. With a diverse range of services, Belfius Bank also engages in sectors such as insurance and life sciences. The governance and management of the bank's assets are overseen by its Board of Directors, ensuring responsible stewardship and alignment with community interests.

Nausicaa Ventures, established in 2009, is a Belgium-based early-stage venture capital firm. It invests in early growth and early-stage companies primarily in Belgium, with a focus on projects within a 300 km radius of Brussels, extending to France, Luxembourg, Netherlands, Switzerland, and the United Kingdom. The firm targets investments in healthcare, medtech, ICT, manufacturing, clean technology, and high-tech industries, typically investing between €1 million to €4 million per company. Nausicaa Ventures prefers to invest alongside angel investors or family offices and has an average holding period of five years, aiming to exit after three to six years.

Societe Generale is a prominent financial services organization founded in 1864 and headquartered in Paris, France. With a strong international presence, particularly in the UK since 1871, it offers a wide range of services including retail, corporate, and investment banking. The firm specializes in areas such as capital markets, securities, underwriting, mergers and acquisitions, derivatives, trading, as well as clearing, settlement, and custodial services. Societe Generale serves a diverse clientele across various sectors, including financial institutions, energy, utilities, telecommunications, and aerospace. The company prioritizes innovation in its offerings to empower clients in both their personal and professional endeavors, while also actively engaging in community support initiatives through its corporate social responsibility programs. Employing approximately 4,300 individuals in the UK, Societe Generale is committed to fostering strong relationships with corporate entities, investors, and government organizations to enhance its service delivery.

Gilde Healthcare, established in 1982 and headquartered in Utrecht, Netherlands, is a leading venture capital firm specializing in the healthcare sector. With over €800 million under management, the firm invests in digital health, diagnostics, medical devices, therapeutics, and healthcare services across Europe and North America. Gilde focuses on growth capital and buyout opportunities, typically investing between €1 million and €40 million per transaction, with a preference for majority or significant minority stakes. The firm seeks to be the lead investor and take a board seat, aiming to exit through IPOs, strategic sales, or private placements. Gilde's portfolio spans various healthcare sub-sectors, with a particular emphasis on cardiology, oncology, and women's health.